Aura Biosciences reports Q2 GAAP EPS of -$0.48, missing estimates by $0.10

Earnings
โดย Seeking Alpha·Read original
Summary · why it matters

Aura Biosciences reported a second-quarter GAAP loss of $0.48 per share, missing analyst estimates by $0.10. As of June 30, 2026, the company held $323.8 million in cash, cash equivalents, and marketable securities. Management believes these resources are sufficient to fund operations into the first half of 2029.

Impact on stocks 1

Biotech & Genomic Medicine▼ · 1 stocks
© 2026 MarketDXNews